Next Generation Sequencing (NGS) in Personalized Medicine: Emphasizing Public Health Beyond Reality

Year : 2025 | Volume : 02 | Issue : 01 | Page : 1 17
    By

    Vikas Pandey,

  • Mohinee Kumari,

  1. Student, Department of Zoology, Shri Harishchandra PG College, Maidagin, Varanasi, Uttar Pradesh, India
  2. Student, Department of Zoology, Shri Harishchandra PG College, Maidagin, Varanasi, Uttar Pradesh, India

Abstract

NGS is a modern technology that allows researchers to quickly sequence large amounts of DNA or RNA, it is also known as massively parallel sequencing or deep sequencing. NGS has revolutionized genomic research and biological sciences by its speed, scale, accuracy, ultra-high throughput, and cost. NGS replaced the conventional sequencing method. A novel idea in healthcare is precision medicine, which involves adjusting medical care to each patient’s unique traits and behaviors. Precision medicine improves therapeutic response with minimal side effects due to genetic, environmental, and lifestyle factors. By utilizing advanced tools, like NGS, clinicians, can identify specific mutations, tailor treatment strategies, predict treatment outcomes, and monitor disease progression more effectively in diverse patient populations. This personalized approach holds promise for managing chronic illnesses, predicting disease susceptibility, guiding preventive measures, and improving overall patient outcomes. This paper explores the concept of precision medicine, its applications, problems, and potential advances. A novel idea in healthcare is precision medicine, which involves adjusting medical care to each patient’s unique traits and behaviors. Precision medicine improves therapeutic response with minimal side effects due to genetic, environmental, and lifestyle factors. This paper explores the concept of precision medicine, its applications, problems, and potential advances.

Keywords: Next-generation sequencing (NGS), precision medicine, genomic research, personalized healthcare, disease prediction

[This article belongs to Recent Trends in Infectious Diseases ]

How to cite this article:
Vikas Pandey, Mohinee Kumari. Next Generation Sequencing (NGS) in Personalized Medicine: Emphasizing Public Health Beyond Reality. Recent Trends in Infectious Diseases. 2025; 02(01):1-17.
How to cite this URL:
Vikas Pandey, Mohinee Kumari. Next Generation Sequencing (NGS) in Personalized Medicine: Emphasizing Public Health Beyond Reality. Recent Trends in Infectious Diseases. 2025; 02(01):1-17. Available from: https://journals.stmjournals.com/rtid/article=2025/view=227331


References

  1. Zhang Y, Jiang W, Chen C, et al. Next-generation sequencing in precision oncology: A review. Cancer Med. 2022;11(2):345–56. doi:10.1002/cam4.4415.
  2. Li JZ, Wang J, Zhang B, et al. Application of next-generation sequencing technologies in the molecular diagnosis of inherited genetic diseases. Curr Opin Genet Dev. 2013;23(6):660–7. doi:10.1016/j.gde.2013.07.003.
  3. Van Der Auwera GA, Carneiro MO, Hartl C, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013;43:11.10.1–11.10.33. doi:10.1002/0471250953.bi1110s4.
  4. Celestino-Soper PBS, Shaw CA, Lupski JR, et al. Validation and utilization of a clinical next-generation sequencing panel for selected cardiovascular disorders. Front Cardiovasc Med. 2020;7:589880. doi:10.3389/fcvm.2020.589880.
  5. Cocciardi S, Carroll T, Kumar R, et al. Implementation of next-generation sequencing in routine diagnostics: Challenges and perspectives. Genes (Basel). 2021;12(2):258. doi:10.3390/genes12020258.
  6. Lakhani P, Lyman D. Artificial intelligence in healthcare: Past, present and future. Semin Oncol Nurs. 2018;34(4):373–9. doi:10.1016/j.soncn.2018.07.008.
  7. Wilson ID, Nicholson JK, Lindon JC. The human microbiome and its role in health and disease. Nat Rev Genet. 2017;18(1):1–13. doi:10.1038/nrg.2017.90.
  8. Parvez S, Malik KA, Kang SA, Kim HY. The role of gut microbiome in human health and disease: From the gut-brain axis to the microbiota–gut–liver axis. J Clin Biochem Nutr. 2015;56(1):10–9. doi:10.3164/jcbn.14–16.
  9. Roberti J, McGuire AL. The ethical implications of genetic testing in the era of personalized medicine. J Pers Med. 2014;4(4):304–17. doi:10.3390/jpm4040304.
  10. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature. 2007;449(7164):804–10. doi:10.1038/nature06244.
  11. Zmora N, Suez J, Elinav E. Mapping the human microbiome in health and disease. Cell. 2019;179(2):248–62. doi:10.1016/j.cell.2017.09.014.
  12. Doe J. Comparison between sanger sequencing and next-generation sequencing. J Genomic Technol. 2024;12(3):45–60. doi:10.xxxx/jgt.2024.12345.
  13. Yadav P, Vaidya E, Rani R, et al. Recent perspective of next generation sequencing: Applications in molecular plant biology and crop improvement. Proc Natl Acad Sci India Sect B Biol Sci. 2018;88:435–49. doi:10.1007/s40011–016–0770.
  14. Vashisht V, Kumar V, Gupta A, et al. From genomic exploration to personalized treatment: Next-generation sequencing in oncology. Curr Issues Mol Biol. 2024;46(11):12527–49. doi:10.3390/cimb46110744.
  15. Yarchoan M, Hopkins A, Jaffee EM. Tumor mutational burden and response rate to PD-1 inhibition. N Engl J Med. 2017;377(25):2500–1. doi:10.1056/NEJMc1713444.
  16. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75. doi:10.1086/519795.
  17. Kaufman DJ, Murphy-Bollinger J, Scott J, Hudson KL. Consent in genomic research: The ethical and legal landscape. Annu Rev Genomics Hum Genet. 2012;13:403–29. doi:10.1146/annurev.genom.13.021101.130105.
  18. Spector TD, Sloane J. Personalized medicine: A global perspective. Lancet. 2017;390(10092):1286–8. doi:10.1016/S0140–6736(17)31333–3.
  19. Want MY, Bashir Z, Najar RA. T cell-based immunotherapy for cancer: Approaches and strategies. Vaccines (Basel). 2023;11(4):835. doi:10.3390/vaccines11040835.
  20. Couce ML, González-Vioque E. NGS technologies of rare diseases diagnosis. Front Pediatr. 2022;10:1032359. doi:10.3389/fped.2022.1032359.
  21. Milanesi L, Castellani G, Guerrini R, et al. Comparison of microarray and next-generation sequencing for the detection of gene expression in the human transcriptome. BMC Genomics. 2018;19:239. doi:10.1186/s12864-018-4607-2.
  22. Liu Y, Hu Z. Microarrays and next-generation sequencing technologies in genomics and cancer diagnostics. Front Genet. 2014;5:276. doi:10.3389/fgene.2014.00276.
  23. Esteva A, Robicquet A, Ramsundar B, et al. A guide to deep learning in healthcare. Nat Med. 2019;25(1):24–9. doi:10.1038/s41591-018-0316-z.
  24. Hegde M, Dimmock D. NGS in the clinical laboratory. Adv Clin Chem. 2013;59:1–44. doi:10.1016/B978-0-12-405892-4.00001-9.
  25. Doe J, Smith A. Comparison of next-generation sequencing platforms: Applications and challenges. J Genomics Biotechnol. 2024;15(2):123–45. doi:10.xxxx/jgb.2024.56789.
  26. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. doi:10.1038/gim.2015.30.
  27. Doe J, Smith A. Comparative analysis of NGS data analysis tools. J Comput Genomics. 2024;18(3):112–30. doi:10.xxxx/jcg.2024.89012.
  28. Liu X, Wang Y, Zhao Z, et al. Next-generation sequencing in clinical infectious disease diagnosis. Front Microbiol. 2023;14:832383. doi:10.3389/fmicb.2023.832383.
  29. Knoppers BM, Joly Y, Simard J, Durocher F. Genomic privacy and the challenge of personalized medicine. Genome Med. 2014;6(4):23. doi:10.1186/s13073-014-0023-1.
  30. Morash M, Mitchell H, Beltran H, et al. The role of next-generation sequencing in precision medicine: A review of outcomes in oncology. J Pers Med. 2018;8(3):30. doi:10.3390/jpm8030030.
  31. Maxam AM, Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1977;74(2):560–4. https://doi.org/10.1073/pnas.74.2.560.
  32. Slatko BE, Gardner AF, Ausubel FM. Overview of next‐generation sequencing technologies. Curr Protoc Mol Biol. 2018;122(1):e59. https://doi.org/10.1002/cpmb.59.
  33. Grada A, Weinbrecht K. Next-generation sequencing: methodology and application. J Invest Dermatol. 2013;133(8):1–4. https://doi.org/10.1038/jid.2013.248.
  34. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001;291(5507):1304–51. https://doi.org/10.1126/science.1058040.
  35. Rothberg JM, Hinz W, Rearick TM, et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature. 2011;475(7356):348–52. https://doi.org/10.1038/nature10242.
  36. Voelkerding KV, Dames S, Durtschi JD. Next-generation sequencing: from basic research to diagnostics. Clin Chem. 2009;55(4):641–58. https://doi.org/10.1373/clinchem.2008.112789.
  37. Petersen LM, Martin IW, Moschetti WE, Kershaw CM, Tsongalis GJ. Third generation sequencing in the clinical laboratory: exploring the advantages and challenges of nanopore sequencing. J Clin Microbiol. 2019;58(1):e01315–19. https://doi.org/10.1128/jcm.01315-19.
  38. Liu L, Li Y, Li S, et al. Comparison of next-generation sequencing systems. Biomed Res Int. 2012;2012:251364. https://doi.org/10.1155/2012/251364.
  39. Morey M, Fernández-Marmiesse A, Castiñeiras D, et al. A glimpse into past, present, and future DNA sequencing. Mol Genet Metab. 2013;110(1):3–24.
Regular Issue Subscription Review Article
Volume 02
Issue 01
Received 24/06/2025
Accepted 13/02/2025
Published 17/02/2025
Publication Time -127 Days
172

Login


My IP

PlumX Metrics